Third-Generation Sequencing Technology Global Market Report 2025
상품코드:1855994
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
3세대 시퀀스 기술 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 122억 5,000만 달러에서 2025년에는 140억 달러로, CAGR 14.2%로 확대합니다. 실적 기간의 성장은 롱 리드 시퀀싱 수요 증가, 시퀀싱 비용 감소, 실시간 병원체 검출의 필요성, 맞춤형 의료, 임상 진단의 확대, 정밀농업의 등장으로 인해 이루어졌습니다.
3세대 시퀀싱 기술 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 13.8%로 23억 5,510만 달러로 성장할 것입니다. 예측 기간 중 시장 개발은 만성질환 및 감염성 질환의 확산, 임상 진단에 대한 광범위한 적용, 비인간 유전체학으로의 확장, 정부 및 민간 자금 지원 확대, 신흥 시장에서의 시퀀싱 인프라 구축 등이 지원할 것으로 예측됩니다. 예측 기간 중 예상되는 주요 동향으로는 고급 데이터 분석을 위한 인공지능의 통합, 실시간 휴대용 시퀀싱 장비의 개발, 롱 리드 시퀀싱 정확도 향상, 광범위한 접근성을 위한 시퀀싱 비용 절감, 맞춤형 의료 용도의 발전 등이 있습니다.
3세대 시퀀싱 기술은 한 분자를 실시간으로 읽고, 종종 중합효소 연쇄반응에 의한 증폭 없이도 긴 연속 리드를 생성할 수 있는 첨단 DNA 또는 RNA 시퀀싱 방법을 말합니다. 주요 목적은 정확하고 종합적인 유전체 및 전사체 정보를 제공하는 것으로, 구조적 변이, 후성유전학적 변화 및 이전 시퀀싱 방법으로는 분석이 어려웠던 복잡한 영역의 식별을 가능하게 합니다.
3세대 시퀀서의 주요 기술 유형에는 1분자 실시간 시퀀싱, 전사 매개 증폭, 나노포아 시퀀싱, 합성 시퀀싱, 기타 등이 있습니다. 1분자 실시간 시퀀싱은 효소에 의한 DNA 합성을 실시간으로 모니터링하고, 템플릿 증폭 없이 각 염기의 형광 신호를 포착하는 첨단 접근법입니다. 워크플로는 샘플 준비, 시퀀싱, 데이터 분석, 데이터 저장 또는 관리로 구성되며, 유전체학, 전사체학, 후성유전체학, 메타유전체학, 맞춤의료, 합성생물학 등에 적용됩니다. 이러한 방법은 학술기관, 임상 실험실, 제약 및 생명공학 기업, 연구 기관, 정부 및 비영리 기관 등의 최종사용자들이 사용하고 있습니다.
2025년 봄 미국의 갑작스러운 관세 인상과 이에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단기기, 의약품공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.
3세대 시퀀싱 기술 산업 세계 시장 규모, 지역별 점유율, 3세대 시퀀싱 기술 시장 점유율을 보유한 경쟁사, 상세한 3세대 시퀀싱 기술 시장 부문, 시장 동향, 비즈니스 기회 등 3세대 시퀀싱 기술 시장 통계를 제공하는 The Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 3세대 시퀀싱 기술 시장 조사 보고서는 업계의 현재와 미래 시나리오에 대한 상세한 분석을 통해 필요한 모든 것을 완벽하게 전망합니다.
맞춤형 의료의 이용 증가는 향후 3세대 시퀀싱 기술 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 체질, 생활습관, 환경에 따라 치료와 예방조치를 맞춤화하는 접근법입니다. 이 접근법이 인기를 얻고 있는 이유는 유전체학의 발전으로 유전자의 차이를 정확하게 파악하여 보다 정확한 치료를 가능하게 하기 때문입니다. 3세대 시퀀싱 기술은 유전적 변이를 식별하는 데 도움이 되는 장기간의 고정밀 유전체 데이터를 제공함으로써 맞춤형 의료를 지원합니다. 이 기술은 개인 유전체에 대한 심층 인사이트를 통해 개인 맞춤형 치료 계획에 기여하고, 임상 결과를 개선하며, 정밀의료를 촉진할 수 있습니다. 예를 들어 2024년 2월 미국 비영리단체인 맞춤형 의료연합(PMC)은 미국 식품의약국(FDA)이 2023년 26개의 개인맞춤형 신약을 승인했다고 보고했습니다. 이러한 맞춤형 의료의 채택 증가는 3세대 시퀀싱 기술 시장 성장의 주요 요인으로 작용하고 있습니다.
3세대 시퀀싱 기술 시장의 주요 기업은 연구 효율성을 높이고, 임상 적용을 개선하고, 납기와 비용을 절감하기 위해 초고속 및 확장 가능한 시퀀싱 시스템과 같은 첨단 시퀀싱 플랫폼을 개발하기 위해 노력하고 있습니다. 이러한 시퀀싱 시스템은 뛰어난 속도와 정확도로 높은 처리량, 실시간 유전체 분석을 제공하는 혁신적인 기술로, 다양한 용도에서 상세한 유전체 프로파일링을 가능하게 합니다. 예를 들어 2025년 2월 스위스에 본사를 둔 제약회사 Roche Holding AG는 SBX(Sequencing by Expansion) 기술을 발표했습니다. 이 완전히 통합된 차세대 시퀀싱 시스템은 특허 받은 생화학 공정을 통해 DNA 또는 RNA 서열을 Xpandomers라고 불리는 측정 가능한 서로게이트 폴리머로 변환하여 정밀한 단일 분자 나노포어 시퀀싱을 가능하게 합니다. SBX 플랫폼은 초고속, 확장 가능한 시퀀싱 기능과 자동 데이터 분석 기능을 갖추고 있으며, 대규모 수작업이 필요 없이 몇 일이 아닌 몇 시간 만에 전체 유전체 시퀀싱 결과를 얻을 수 있습니다.
2022년 2월, 미국 생명공학기업인 엘리먼트 바이오사이언스(Element Biosciences)는 조건은 공개되지 않았지만 루프제노믹스(Loop Genomics)를 인수했습니다. 이번 인수를 통해 Element Biosciences는 Loop Genomics의 합성 롱리드 기술을 도입하여 시퀀서 포트폴리오를 강화할 예정입니다. 이번 인수를 통해 엘리먼트 바이오사이언스의 유전체학, 전사체학, 마이크로바이옴 연구 역량이 강화될 것으로 기대됩니다. 루프지노믹스(Loop Genomics Inc.)는 미국에 본사를 둔 생명공학 기업으로, 합성 롱리드 기술을 통한 3세대 시퀀싱 기술 개발을 전문으로 하는 기업입니다.
3세대 시퀀싱 기술 시장은 전장유전체 시퀀싱, 전사체 시퀀싱, 후성유전체 분석, de novo 유전체 어셈블리, 단일세포 시퀀싱, 구조적 변이체 검출 등의 서비스를 제공하는 사업체의 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치가 포함됩니다. 3세대 시퀀싱 기술 시장에는 시퀀싱 장비, 시약, 플로우 셀, 시료 전처리 키트, 나노포어 디바이스, 광학 매핑 시스템, 마이크로플루이딕스 칩, 시료 전처리 장비의 매출도 포함됩니다. 이 시장의 가치는 '팩토리 게이트' 가치, 즉 상품의 제조자 또는 제작자가 다른 사업체(다운스트림 제조자, 도매업체, 유통업체, 소매업체 등) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 3세대 시퀀스 기술 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 3세대 시퀀스 기술 시장 : 성장률 분석
세계의 3세대 시퀀스 기술 시장 실적 : 규모와 성장, 2019-2024
세계의 3세대 시퀀스 기술 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 3세대 시퀀스 기술 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 3세대 시퀀스 기술 시장 : 기술 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 분자 실시간 시퀀스(SMRT)
전사 매개 증폭(TMA)
나노포어 시퀀스
합성에 의한 시퀀스(SBS)
기타 기술
세계의 3세대 시퀀스 기술 시장 : 워크플로우별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
샘플 조제
시퀀싱
데이터 분석
데이터 해석
데이터 보존과 관리
세계의 3세대 시퀀스 기술 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유전체학
전사체학
에피게노믹스
군유전체학
맞춤형 의료
합성생물학
세계의 3세대 시퀀스 기술 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
학술기관
임상 연구소
제약·바이오테크놀러지 기업
연구기관
정부기관 및 비영리단체
세계의 3세대 시퀀스 기술 시장 : 서브 세분화 단일 분자 실시간 시퀀스(SMRT), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제로 모드 도파관(ZMWs)
서큘러 컨센서스 시퀀스(CCS)
HiFi(High-Fidelity) 리드
세계의 3세대 시퀀스 기술 시장 : 서브 세분화 전사 매개 증폭(TMA), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정성적 전사 매개 증폭(TMA) 어세이
정량 전사 매개 증폭(TMA) 어세이
다중 전사 매개 증폭(TMA) 어세이
세계의 3세대 시퀀스 기술 시장 : 서브 세분화 나노포어 시퀀스, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
포터블 나노포어 시퀀서
벤치탑 나노포어·시퀸서
하이스루풋(High throughput) 나노포어 플랫폼
세계의 3세대 시퀀스 기술 시장 : 서브 세분화 합성에 의한 시퀀스(SBS), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
가역적 터미네이터 화학
합성에 의한 실시간 시퀀스(SBS) 플랫폼
합성에 의한 쇼트 리드 시퀀스(SBS)
합성(SBS)에 의한 롱 리드 시퀀스
세계의 3세대 시퀀스 기술 시장 : 서브 세분화 기타 기술 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
하이브리드 시퀀스 플랫폼
파이로시퀀스
이온 반도체 시퀸서
새로운 실험 방법
제7장 지역별·국가별 분석
세계의 3세대 시퀀스 기술 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 3세대 시퀀스 기술 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
3세대 시퀀스 기술 시장 : 경쟁 구도
3세대 시퀀스 기술 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Qiagen N.V.
Macrogen Inc.
Myriad Genetics Inc.
10x Genomics Inc.
Twist Bioscience Corporation
Takara Bio Inc.
Fulgent Genetics Inc.
Oxford Nanopore Technologies Limited
Ultima Genomics Inc.
Element Biosciences Inc.
Sophia Genetics SA
Variantyx Inc.
Quantapore Inc.
Phase Genomics Inc.
Singular Genomics Systems Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
3세대 시퀀스 기술 시장 2029 : 새로운 기회를 제공하는 국가
3세대 시퀀스 기술 시장 2029 : 새로운 기회를 제공하는 부문
3세대 시퀀스 기술 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Third-generation sequencing technology refers to advanced DNA or RNA sequencing methods capable of reading single molecules in real time, often generating long continuous reads without requiring polymerase chain reaction amplification. Its main objective is to deliver highly accurate and comprehensive genomic and transcriptomic information, allowing the identification of structural variants, epigenetic changes, and complex regions that are difficult to analyze using earlier sequencing methods.
The primary technology types of third-generation sequencing include single-molecule real-time sequencing, transcription-mediated amplification, nanopore sequencing, sequencing by synthesis, and others. Single-molecule real-time sequencing is an advanced approach that monitors DNA synthesis by enzymes in real time, capturing fluorescent signals of each base without template amplification. The workflow consists of sample preparation, sequencing, data analysis, and data storage or management, with applications in genomics, transcriptomics, epigenomics, metagenomics, personalized medicine, and synthetic biology. These methods are used by end users such as academic institutions, clinical laboratories, pharmaceutical and biotechnology companies, research organizations, and government or non-profit institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The third-generation sequencing technology market research report is one of a series of new reports from The Business Research Company that provides third-generation sequencing technology market statistics, including the third-generation sequencing technology industry global market size, regional shares, competitors with the third-generation sequencing technology market share, detailed third-generation sequencing technology market segments, market trends, and opportunities, and any further data you may need to thrive in the third-generation sequencing technology industry. This third-generation sequencing technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The third-generation sequencing technology market size has grown rapidly in recent years. It will grow from $12.25 billion in 2024 to $14.00 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. Growth during the historic period was driven by rising demand for long-read sequencing, decreasing sequencing costs, the need for real-time pathogen detection, initiatives in personalized medicine, expansion of clinical diagnostics, and the emergence of precision agriculture.
The third-generation sequencing technology market size is expected to see rapid growth in the next few years. It will grow to $23.51 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. Growth in the forecast period is expected to be supported by the increasing prevalence of chronic and infectious diseases, broader applications in clinical diagnostics, expansion into non-human genomics, greater government and private funding, and the development of sequencing infrastructure in emerging markets. Key trends anticipated for the forecast period include integration of artificial intelligence for advanced data analysis, creation of real-time portable sequencing devices, improvements in long-read sequencing accuracy, reductions in sequencing costs for broader access, and progress in personalized medicine applications.
The rise in the use of personalized medicine is anticipated to drive the expansion of the third-generation sequencing technology market in the future. Personalized medicine is an approach that customizes treatments and preventive measures based on a person's genetic makeup, lifestyle, and environment. The growing popularity of this approach is mainly attributed to advances in genomics, which allow for accurate identification of genetic differences and more precise treatments. Third-generation sequencing technology supports personalized medicine by providing long-read, high-precision genomic data that aids in identifying genetic variations. This technology contributes to personalized treatment plans by offering in-depth insights into individual genomes, thereby improving clinical outcomes and advancing precision healthcare. For example, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization in the U.S., reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from 12 approvals in 2022. This increasing adoption of personalized medicine is a key factor in the growth of the third-generation sequencing technology market.
Leading players in the third-generation sequencing technology market are working on the development of advanced sequencing platforms, such as ultra-rapid and scalable sequencing systems, to enhance research efficiency, improve clinical application, and lower turnaround times and costs. These sequencing systems are innovative technologies that offer high-throughput, real-time genomic analysis with remarkable speed and accuracy, enabling detailed genomic profiling for a wide range of applications. For example, in February 2025, Roche Holding AG, a pharmaceutical company based in Switzerland, introduced Sequencing by Expansion (SBX) technology. This fully integrated next-generation sequencing system uses a patented biochemical process to convert DNA or RNA sequences into measurable surrogate polymers called Xpandomers, allowing for precise single-molecule nanopore sequencing. The SBX platform is equipped with ultra-rapid, scalable sequencing features and automated data analysis, producing whole-genome sequencing results in a matter of hours rather than days without requiring extensive manual work.
In February 2022, Element Biosciences Inc., a biotechnology company based in the U.S., acquired Loop Genomics Inc., a deal for which the terms were not disclosed. With this acquisition, Element Biosciences aims to enhance its sequencing portfolio by incorporating Loop Genomics' synthetic long-read technology. This acquisition is expected to strengthen Element Biosciences' capabilities in genomics, transcriptomics, and microbiome research. Loop Genomics Inc., also a U.S.-based biotechnology firm, specializes in advancing third-generation sequencing technologies through synthetic long-read sequencing solutions.
Major players in the third-generation sequencing technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Macrogen Inc., Myriad Genetics Inc., 10x Genomics Inc., Twist Bioscience Corporation, Takara Bio Inc., Fulgent Genetics Inc., Oxford Nanopore Technologies Limited, Ultima Genomics Inc., Element Biosciences Inc., Sophia Genetics SA, Variantyx Inc., Quantapore Inc., Phase Genomics Inc., and Singular Genomics Systems Inc.
North America was the largest region in the third-generation sequencing technology market in 2024. The regions covered in third-generation sequencing technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the third-generation sequencing technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The third-generation sequencing technology market consists of revenues earned by entities by providing services such as whole genome sequencing, transcriptome sequencing, epigenetic analysis, de novo genome assembly, single-cell sequencing, and structural variant detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The third-generation sequencing technology market also includes sales of sequencing instruments, reagents, flow cells, sample preparation kits, nanopore devices, optical mapping systems, microfluidic chips, and sample preparation instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Third-Generation Sequencing Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on third-generation sequencing technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for third-generation sequencing technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The third-generation sequencing technology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT); Transcription-Mediated Amplification (TMA); Nanopore Sequencing; Sequencing By Synthesis (SBS); Other Technology Types
2) By Workflow: Sample Preparation; Sequencing; Data Analysis; Data Interpretation; Data Storage And Management
4) By End-User: Academic Institutions; Clinical Laboratories; Pharmaceutical And Biotechnology Companies; Research Organizations; Government And Non-Profit Organizations
4) By Sequencing By Synthesis (SBS): Reversible Terminator Chemistry; Real-Time Sequencing By Synthesis (SBS) Platforms; Short-Read Sequencing By Synthesis (SBS); Long-Read Sequencing By Synthesis (SBS)
5) By Other Technology Types: Hybrid Sequencing Platforms; Pyrosequencing; Ion Semiconductor Sequencing; Emerging Experimental Methods
3. Third-Generation Sequencing Technology Market Trends And Strategies
4. Third-Generation Sequencing Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Third-Generation Sequencing Technology Growth Analysis And Strategic Analysis Framework
5.1. Global Third-Generation Sequencing Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Third-Generation Sequencing Technology Market Growth Rate Analysis
5.4. Global Third-Generation Sequencing Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Third-Generation Sequencing Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Third-Generation Sequencing Technology Total Addressable Market (TAM)
6.7. Global Third-Generation Sequencing Technology Market, Sub-Segmentation Of Nanopore Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Portable Nanopore Sequencers
Benchtop Nanopore Sequencers
High-Throughput Nanopore Platforms
6.8. Global Third-Generation Sequencing Technology Market, Sub-Segmentation Of Sequencing By Synthesis (SBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reversible Terminator Chemistry
Real-Time Sequencing By Synthesis (SBS) Platforms
Short-Read Sequencing By Synthesis (SBS)
Long-Read Sequencing By Synthesis (SBS)
6.9. Global Third-Generation Sequencing Technology Market, Sub-Segmentation Of Other Technology Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hybrid Sequencing Platforms
Pyrosequencing
Ion Semiconductor Sequencing
Emerging Experimental Methods
7. Third-Generation Sequencing Technology Market Regional And Country Analysis
7.1. Global Third-Generation Sequencing Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Third-Generation Sequencing Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Third-Generation Sequencing Technology Market
9.1. China Third-Generation Sequencing Technology Market Overview
9.2. China Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Third-Generation Sequencing Technology Market
10.1. India Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Third-Generation Sequencing Technology Market
11.1. Japan Third-Generation Sequencing Technology Market Overview
11.2. Japan Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Third-Generation Sequencing Technology Market
12.1. Australia Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Third-Generation Sequencing Technology Market
13.1. Indonesia Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Third-Generation Sequencing Technology Market
14.1. South Korea Third-Generation Sequencing Technology Market Overview
14.2. South Korea Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Third-Generation Sequencing Technology Market
15.1. Western Europe Third-Generation Sequencing Technology Market Overview
15.2. Western Europe Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Third-Generation Sequencing Technology Market
16.1. UK Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Third-Generation Sequencing Technology Market
21.1. Eastern Europe Third-Generation Sequencing Technology Market Overview
21.2. Eastern Europe Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Third-Generation Sequencing Technology Market
22.1. Russia Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Third-Generation Sequencing Technology Market
23.1. North America Third-Generation Sequencing Technology Market Overview
23.2. North America Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Third-Generation Sequencing Technology Market
24.1. USA Third-Generation Sequencing Technology Market Overview
24.2. USA Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Third-Generation Sequencing Technology Market
26.1. South America Third-Generation Sequencing Technology Market Overview
26.2. South America Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Third-Generation Sequencing Technology Market
27.1. Brazil Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Third-Generation Sequencing Technology Market
28.1. Middle East Third-Generation Sequencing Technology Market Overview
28.2. Middle East Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Third-Generation Sequencing Technology Market
29.1. Africa Third-Generation Sequencing Technology Market Overview
29.2. Africa Third-Generation Sequencing Technology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Third-Generation Sequencing Technology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Third-Generation Sequencing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Third-Generation Sequencing Technology Market Competitive Landscape And Company Profiles
